Skip to main navigation Skip to search Skip to main content

Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial

  • Kim Broekhuijsen*
  • , Gert-Jan van Baaren
  • , Maria G. van Pampus
  • , Wessel Ganzevoort
  • , J. Marko Sikkema
  • , Mallory D. Woiski
  • , Martijn A. Oudijk
  • , Kitty W. M. Bloemenkamp
  • , Hubertina C. J. Scheepers
  • , Henk A. Bremer
  • , Robbert J. P. Rijnders
  • , Aren J. van Loon
  • , Denise A. M. Perquin
  • , Jan M. J. Sporken
  • , Dimitri N. M. Papatsonis
  • , Marloes E. van Huizen
  • , Corla B. Vredevoogd
  • , Jozien T. J. Brons
  • , Mesrure Kaplan
  • , Anton H. van Kaam
    • Henk Groen, Martina M. Porath, Paul P. van den Berg, Ben W. J. Mol, Maureen T. M. Franssen, Josje Langenveld
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science